Archive ready

医薬品医療機器等法に基づく新型コロナウイルスワクチンの特例承認について｜厚生労働省

https://www.mhlw.go.jp/stf/newpage_18787.html

April 9, 2026 at 03:01 AM JST•The archive page, viewer, and downloads use this saved version.

April 9, 2026 at 03:01 AM JST·www.mhlw.go.jp

The evidence pack includes HTML, screenshots, summaries, and metadata. It can be downloaded on Pro.

Saved page

医薬品医療機器等法に基づく新型コロナウイルスワクチンの特例承認について｜厚生労働省

Open the archived HTML with saved-time metadata attached.

Original URLhttps://www.mhlw.go.jp/stf/newpage_18787.html

StartedApril 9, 2026 at 03:01 AM JST

This HTML has CSS and images embedded, so it can still be opened even if the original page disappears.

About this pageAI generated

This page is an official announcement by Japan's Ministry of Health, Labour and Welfare dated May 21, 2021, regarding conditional approval of COVID-19 vaccines. Two vaccines received conditional approval under the Pharmaceutical Affairs Law: AstraZeneca's "Vaxzevria" and Takeda Pharmaceutical's "COVID-19 Vaccine Moderna." Both products are approved for preventing SARS-CoV-2 infection. The announcement includes product details, applicants, application dates, and indications.

Screenshot

The full page can be captured up to 15,000px in height so you can review the complete page layout when needed.